Drug Profile
Research programme: anti-anthrax monoclonal antibody - iBio
Alternative Names: PA monoclonal antibody - iBio; Protective antigen monoclonal antibody - iBioLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator iBio Inc
- Class Monoclonal antibodies
- Mechanism of Action Bacterial toxin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Anthrax